Dr. Fischer ISC LB3 stroke treatment options defined

Urs Fischer, M.D. M.Sc., co-principal investigator of the DISTAL trial and director of neurology at the University Hospital Bern in Switzerland discusses the trial (LB 3) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

News release

Transcript (txt)

Please see AHA/ASA Multimedia Materials Usage Policy.

I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use

Download (110.5 MB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED